{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921v1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10135","date":"2024-05-15T18:23:47.426Z","role":"Publisher"},{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10135","date":"2024-05-15T17:00:00.000Z","role":"Approver"}],"curationReasons":{"id":"cg:NewCuration"},"earliestArticle":{"id":"https://pubmed.ncbi.nlm.nih.gov/29304374","type":"dc:BibliographicResource","dc:abstract":"Fucosyltransferase 8 (FUT8) encodes a Golgi-localized α1,6 fucosyltransferase that is essential for transferring the monosaccharide fucose into N-linked glycoproteins, a process known as \"core fucosylation.\" Here we describe three unrelated individuals, who presented with intrauterine growth retardation, severe developmental and growth delays with shortened limbs, neurological impairments, and respiratory complications. Each underwent whole-exome sequencing and was found to carry pathogenic variants in FUT8. The first individual (consanguineous family) was homozygous for c.715C>T (p.Arg239","dc:creator":"Ng BG","dc:date":"2018","dc:title":"Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation."},"evidence":[{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:27a81cdc-cdb4-4959-a8f3-879cce2ebcba_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:27a81cdc-cdb4-4959-a8f3-879cce2ebcba","type":"Proband","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":7,"allele":{"id":"cggv:52a33d7b-f5da-4ffe-b70c-ade3e2336066","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.943C>T (p.Arg315Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390244424"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0002827","obo:HP_0000577","obo:HP_0004322","obo:HP_0000938","obo:HP_0001249","obo:HP_0000252","obo:HP_0002783","obo:HP_0000520","obo:HP_0001007","obo:HP_0011344","obo:HP_0034392","obo:HP_0003196","obo:HP_0011968","obo:HP_0000485","obo:HP_0001508","obo:HP_0001252","obo:HP_0002751","obo:HP_0000341"],"previousTesting":false,"sex":"Male","variant":{"id":"cggv:082d74aa-c07e-4d78-9e9e-fb15f1508b86_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:52a33d7b-f5da-4ffe-b70c-ade3e2336066"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374"},"rdfs:label":"Ng CDG-0464"},{"id":"cggv:082d74aa-c07e-4d78-9e9e-fb15f1508b86","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:082d74aa-c07e-4d78-9e9e-fb15f1508b86_variant_evidence_item"},{"id":"cggv:082d74aa-c07e-4d78-9e9e-fb15f1508b86_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2)."}],"strengthScore":1.5,"dc:description":"Downgraded for consanguinity since only one functional study was performed."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ea73109d-301f-4056-b0ea-615d4d437c39_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ea73109d-301f-4056-b0ea-615d4d437c39","type":"Proband","allele":{"id":"cggv:cd133434-0f9f-4c1b-ad61-8ce887a57924","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.715C>T (p.Arg239Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390119426"}},"detectionMethod":"Trio sequencing","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001195","obo:HP_0000431","obo:HP_0000821","obo:HP_0009826","obo:HP_0000278","obo:HP_0001250","obo:HP_0000218","obo:HP_0001875","obo:HP_0001511","obo:HP_0001561","obo:HP_0001508","obo:HP_0000121","obo:HP_0001252","obo:HP_0000252","obo:HP_0004322","obo:HP_0011968","obo:HP_0011344","obo:HP_0001249","obo:HP_0001643","obo:HP_0002098","obo:HP_0001631"],"previousTesting":true,"previousTestingDescription":"All biochemical and molecular testing normal. Chromosomal microarray showed large regions of homozygosity consistent with consanguineous parents.","sex":"Female","variant":{"id":"cggv:0e94c656-049d-422c-ae35-df89e781958e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:cd133434-0f9f-4c1b-ad61-8ce887a57924"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374"},"rdfs:label":"Ng CDG-0448"},{"id":"cggv:0e94c656-049d-422c-ae35-df89e781958e","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:0e94c656-049d-422c-ae35-df89e781958e_variant_evidence_item"},{"id":"cggv:0e94c656-049d-422c-ae35-df89e781958e_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"WB revealed no detectable FUT8 protein in patient fibroblasts. LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2). LC-MS on fibroblasts showed complete loss of core fucosylated N-glycans as compared to healthy unaffected controls (N = 3). FACS on patient fibroblasts displayed profound deficiencies in LcH and PSA lectin reactivity."}],"strengthScore":2,"dc:description":"Did not downgrade for consanguinity since multiple functional studies performed."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:bc45462d-14f2-4aac-afb6-35547ddef7c4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:bc45462d-14f2-4aac-afb6-35547ddef7c4","type":"Proband","allele":{"id":"cggv:1a96dc2f-33dc-4dbb-91ea-2c6688ed7d1d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.716G>A (p.Arg239Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390119427"}},"detectionMethod":"WES","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000787","obo:HP_0001250","obo:HP_0011968","obo:HP_0000821","obo:HP_0000377","obo:HP_0002783","obo:HP_0011344","obo:HP_0002119","obo:HP_0001249","obo:HP_0000252","obo:HP_0001252","obo:HP_0001508","obo:HP_0004322"],"previousTesting":false,"sex":"Male","variant":{"id":"cggv:56a8e665-8fa2-498f-9e4d-07187ee3e500_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1a96dc2f-33dc-4dbb-91ea-2c6688ed7d1d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/32049367","type":"dc:BibliographicResource","dc:abstract":"Pathogenic variants in the Golgi localised alpha 1,6 fucosyltransferase, FUT8, cause a rare inherited metabolic disorder known as FUT8-CDG. To date, only three affected individuals have been reported presenting with a constellation of symptoms including intrauterine growth restriction, severe delays in growth and development, other neurological impairments, significantly shortened limbs, respiratory complications, and shortened lifespan. Here, we report an additional four unrelated affected individuals homozygous for novel pathogenic variants in FUT8. Analysis of serum N-glycans revealed a complete lack of core fucosylation, an important diagnostic biomarker of FUT8-CDG. Our data expands both the molecular and clinical phenotypes of FUT8-CDG and highlights the importance of identifying a reliable biomarker for confirming potentially pathogenic variants.","dc:creator":"Ng BG","dc:date":"2020","dc:title":"Expanding the molecular and clinical phenotypes of FUT8-CDG."}},"rdfs:label":"Ng CDG-0096"},{"id":"cggv:56a8e665-8fa2-498f-9e4d-07187ee3e500","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:56a8e665-8fa2-498f-9e4d-07187ee3e500_variant_evidence_item"},{"id":"cggv:56a8e665-8fa2-498f-9e4d-07187ee3e500_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"MALDI-TOF showed loss of serum core fucosylated N-glycans."}],"strengthScore":0.25,"dc:description":"Reduced scoring due to consanguinity and only one functional study."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:42d0d517-e842-4079-a2a5-c5db359c1876_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:42d0d517-e842-4079-a2a5-c5db359c1876","type":"Proband","allele":[{"id":"cggv:db0b2ac9-a31d-43d1-a823-026bfbfecdee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1259+5G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658824634"}},{"id":"cggv:d1636ce7-c096-4cfd-b419-f88ed103fda6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1009C>G (p.Arg337Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390245370"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0011344","obo:HP_0009826","obo:HP_0001943","obo:HP_0000501","obo:HP_0000557","obo:HP_0004322","obo:HP_0002099","obo:HP_0002878","obo:HP_0001249","obo:HP_0000337","obo:HP_0001511","obo:HP_0000252","obo:HP_0011968","obo:HP_0001252","obo:HP_0000348","obo:HP_0001561","obo:HP_0001250"],"previousTesting":false,"sex":"Female","variant":[{"id":"cggv:bb673099-853a-4a7d-a3e7-2539a9b94209_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d1636ce7-c096-4cfd-b419-f88ed103fda6"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374"},{"id":"cggv:c0a06f44-9b20-4285-9d27-07f6072805c0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:db0b2ac9-a31d-43d1-a823-026bfbfecdee"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374"}],"rdfs:label":"Ng CDG-0459"},{"id":"cggv:c0a06f44-9b20-4285-9d27-07f6072805c0","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c0a06f44-9b20-4285-9d27-07f6072805c0_variant_evidence_item"},{"id":"cggv:c0a06f44-9b20-4285-9d27-07f6072805c0_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"WB revealed no detectable FUT8 protein in patient fibroblasts. RNA studies (cDNA seq) showed two transcripts - wt and a shorter one. Sanger seq confirmed the short transcript contained an inframe deletion of exon 9. Based on crystal structure analysis, this should affect several critical residues (His363, which recognizes the guanine of GDP-fucose, and Arg365, which recognizes both the β-phosphate of GDP-fucose and the fucose moiety itself, would be deleted.) LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2). LC-MS on patient fibroblasts showed complete loss of core fucosylated N-glycans as compared to healthy unaffected controls (N = 3). FACS on patient fibroblasts displayed profound deficiencies in LcH and PSA lectin reactivity."}],"strengthScore":0.5},{"id":"cggv:bb673099-853a-4a7d-a3e7-2539a9b94209","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:bb673099-853a-4a7d-a3e7-2539a9b94209_variant_evidence_item"},{"id":"cggv:bb673099-853a-4a7d-a3e7-2539a9b94209_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"WB revealed no detectable FUT8 protein in patient fibroblasts. LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2). LC-MS on patient fibroblasts showed complete loss of core fucosylated N-glycans as compared to healthy unaffected controls (N = 3). FACS on patient fibroblasts displayed profound deficiencies in LcH and PSA lectin reactivity."}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:34986a22-0de6-44f1-aa63-ed7e0ad21b3d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:34986a22-0de6-44f1-aa63-ed7e0ad21b3d","type":"Proband","allele":{"id":"cggv:5e68d92c-b94c-4585-a771-352341c3e2cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1302G>A (p.Trp434Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390249214"}},"detectionMethod":"WES","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001561","obo:HP_0001508","obo:HP_0000252","obo:HP_0001249","obo:HP_0002783","obo:HP_0011344","obo:HP_0001528","obo:HP_0011968","obo:HP_0000431","obo:HP_0001252","obo:HP_0004322","obo:HP_0001250","obo:HP_0000278"],"previousTesting":false,"sex":"Female","variant":{"id":"cggv:9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:5e68d92c-b94c-4585-a771-352341c3e2cf"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367"},"rdfs:label":"Ng CDG-0095"},{"id":"cggv:9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3_variant_evidence_item"},{"id":"cggv:9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"MALDI-TOF showed loss of serum core fucosylated N-glycans"}],"strengthScore":1.5,"dc:description":"Subtracted 0.5 pts for consanguinity and only one functional study performed."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0dfc2769-e06b-4d88-aa22-a194959aaa41_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0dfc2769-e06b-4d88-aa22-a194959aaa41","type":"Proband","allele":{"id":"cggv:9cbec722-8912-48bb-b735-b61dc8d6cb37","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1402del (p.Ser468HisfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2625300705"}},"detectionMethod":"Trio WES","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0000252","obo:HP_0000280","obo:HP_0000501","obo:HP_0001252","obo:HP_0011968","obo:HP_0001511","obo:HP_0002650","obo:HP_0001249","obo:HP_0004322","obo:HP_0001508","obo:HP_0000218","obo:HP_0011344","obo:HP_0002783","obo:HP_0000494"],"previousTesting":false,"sex":"Female","variant":{"id":"cggv:5689b8f8-3328-4567-911f-7a7088a3a817_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9cbec722-8912-48bb-b735-b61dc8d6cb37"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367"},"rdfs:label":"Ng CDG-0099"},{"id":"cggv:5689b8f8-3328-4567-911f-7a7088a3a817","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:5689b8f8-3328-4567-911f-7a7088a3a817_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:dbebac02-7d3c-446f-a9bf-37ddfaedad6c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:dbebac02-7d3c-446f-a9bf-37ddfaedad6c","type":"Proband","allele":{"id":"cggv:a3775059-1dc3-4dbf-b259-2ce622944917","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1675C>T (p.Arg559Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7233493"}},"detectionMethod":"WES","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0011003","obo:HP_0005280","obo:HP_0001508","obo:HP_0002827","obo:HP_0100704","obo:HP_0000252","obo:HP_0004322","obo:HP_0011344","obo:HP_0011968","obo:HP_0001252","obo:HP_0001249","obo:HP_0034392","obo:HP_0002650","obo:HP_0006528","obo:HP_0001250"],"previousTesting":false,"sex":"Female","variant":{"id":"cggv:61330835-b570-4331-a6a5-7f9a8bf822e0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a3775059-1dc3-4dbf-b259-2ce622944917"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367"},"rdfs:label":"Ng CDG-0108"},{"id":"cggv:61330835-b570-4331-a6a5-7f9a8bf822e0","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:61330835-b570-4331-a6a5-7f9a8bf822e0_variant_evidence_item"},{"id":"cggv:61330835-b570-4331-a6a5-7f9a8bf822e0_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"MALDI-TOF showed loss of serum core fucosylated N-glycans"}],"strengthScore":1,"dc:description":"Reduced score for consanguinity with minimal testing and because variant is in the last exon and is predicted to be NMD-."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:466c4dfe-96c7-4dc0-be3e-24583cc1a545","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ad414427-54d0-4cac-ba02-79a812112ab7","type":"Finding","demonstrates":{"id":"cg:BiochemicalFunctionB"},"dc:description":"Patients with pathogenic FUT8 mutations have low to no fucosylated glycoforms in their serum.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/27008861","type":"dc:BibliographicResource","dc:abstract":"Understanding the biosynthetic pathway of protein glycosylation in various expression cell lines is important for controlling and modulating the glycosylation profiles of recombinant glycoproteins. We found that expression of erythropoietin (EPO) in a HEK293S N-acetylglucosaminyltransferase I (GnT I)(-/-) cell line resulted in production of the Man5GlcNAc2 glycoforms, in which more than 50% were core-fucosylated, implicating a clear GnT I-independent core fucosylation pathway. Expression of GM-CSF and the ectodomain of FcγIIIA receptor led to ∼30% and 3% core fucosylation, suggesting that the level of core fucosylation also depends on the nature of the recombinant proteins. To elucidate the GnT I-independent core fucosylation pathway, we generated a stable HEK293S GnT I(-/-) cell line with either knockdown or overexpression of FUT8 by a highly efficient lentivirus-mediated gene transfer approach. We found that the EPO produced from the FUT8 knockdown cell line was the pure Man5GlcNAc2 glycoform, whereas that produced from the FUT8-overexpressing cell line was found to be fully core-fucosylated oligomannose glycan (Man5GlcNAc2Fuc). These results provide direct evidence that FUT8, the mammalian α1,6-fucosyltransferase, is the sole enzyme responsible for the GnT I-independent core fucosylation pathway. The production of the homogeneous core-fucosylated Man5GlcNAc2 glycoform of EPO in the FUT8-overexpressed HEK293S GnT I(-/-) cell line represents the first example of production of fully core-fucosylated high-mannose glycoforms.","dc:creator":"Yang Q","dc:date":"2016","dc:title":"Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans."},"rdfs:label":"Yang HEK293S Cell Knockout"}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:7f191430-c492-4fc5-9631-661dc226ac55","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:c9a25e64-05d0-40d6-a4c5-f50ef8cc3402","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Knockout mice exhibited an absence of fucosylated N-glycans, which is also seen in humans. These mice also exhibited early death and smaller size.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/16236725","type":"dc:BibliographicResource","dc:abstract":"The core fucosylation (alpha1,6-fucosylation) of glycoproteins is widely distributed in mammalian tissues, and is altered under pathological conditions. To investigate physiological functions of the core fucose, we generated alpha1,6-fucosyltransferase (Fut8)-null mice and found that disruption of Fut8 induces severe growth retardation and death during postnatal development. Histopathological analysis revealed that Fut8(-/-) mice showed emphysema-like changes in the lung, verified by a physiological compliance analysis. Biochemical studies indicated that lungs from Fut8(-/-) mice exhibit a marked overexpression of matrix metalloproteinases (MMPs), such as MMP-12 and MMP-13, highly associated with lung-destructive phenotypes, and a down-regulation of extracellular matrix (ECM) proteins such as elastin, as well as retarded alveolar epithelia cell differentiation. These changes should be consistent with a deficiency in TGF-beta1 signaling, a pleiotropic factor that controls ECM homeostasis by down-regulating MMP expression and inducing ECM protein components. In fact, Fut8(-/-) mice have a marked dysregulation of TGF-beta1 receptor activation and signaling, as assessed by TGF-beta1 binding assays and Smad2 phosphorylation analysis. We also show that these TGF-beta1 receptor defects found in Fut8(-/-) cells can be rescued by reintroducing Fut8 into Fut8(-/-) cells. Furthermore, exogenous TGF-beta1 potentially rescued emphysema-like phenotype and concomitantly reduced MMP expression in Fut8(-/-) lung. We propose that the lack of core fucosylation of TGF-beta1 receptors is crucial for a developmental and progressive/destructive emphysema, suggesting that perturbation of this function could underlie certain cases of human emphysema.","dc:creator":"Wang X","dc:date":"2005","dc:title":"Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice."},"rdfs:label":"Wang Knockout Mouse"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":8301,"specifiedBy":"GeneValidityCriteria10","strengthScore":14.5,"subject":{"id":"cggv:5fd82050-dbbb-41dd-bdf8-2c9aa2ff3034","type":"GeneValidityProposition","disease":"obo:MONDO_0020775","gene":"hgnc:4019","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"FUT8 was first reported in relation to autosomal recessive congenital disorder of glycosylation with defective fucosylation 1 in 2018 (Ng et al., PMID: 29304374). 8 variants (nonsense, frameshift, splice site, and missense) that have been reported in 7 probands in 2 publications (PMIDs: 29304374, 32049367) are included in this curation. The maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by an animal knockout model (PMID: 16236725) and a cell line knockout model (PMID: 27008861). Both models showed a lack of fucosylated N-glycans, which is also observed in affected patients. In summary, there is definitive evidence supporting the relationship between FUT8 and autosomal recessive congenital disorder of glycosylation with defective fucosylation 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. ","dc:isVersionOf":{"id":"cggv:a593a104-5904-461f-956b-ad1e154df921"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}